Literature DB >> 10564687

Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome.

A Lacroix1, P Hamet, J M Boutin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10564687     DOI： 10.1056/NEJM199911183412104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  45 in total

1.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Cushing's syndrome in pregnancy.

Authors:  N Polli; F Pecori Giraldi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

3.  Adrenocorticotropin-independent Cushing's syndrome in pregnancy related to overexpression of adrenal luteinizing hormone/human chorionic gonadotropin receptors.

Authors:  E Rask; E Schvarcz; P Hellman; J Hennings; F A Karlsson; C V Rao
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

Review 4.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 5.  Medical management of pituitary adenomas: the special case of management of the pregnant woman.

Authors:  Marcello Delano Bronstein; Luiz Roberto Salgado; Nina Rosa de Castro Musolino
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 6.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

7.  Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide.

Authors:  F A Lószió; S Tóth; J Kocsis; M Szécsi
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

8.  Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.

Authors:  Felix Beuschlein; Martin Fassnacht; Guillaume Assié; Davide Calebiro; Constantine A Stratakis; Andrea Osswald; Cristina L Ronchi; Thomas Wieland; Silviu Sbiera; Fabio R Faucz; Katrin Schaak; Anett Schmittfull; Thomas Schwarzmayr; Olivia Barreau; Delphine Vezzosi; Marthe Rizk-Rabin; Ulrike Zabel; Eva Szarek; Paraskevi Salpea; Antonella Forlino; Annalisa Vetro; Orsetta Zuffardi; Caroline Kisker; Susanne Diener; Thomas Meitinger; Martin J Lohse; Martin Reincke; Jérome Bertherat; Tim M Strom; Bruno Allolio
Journal:  N Engl J Med       Date:  2014-02-26       Impact factor: 91.245

9.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

10.  Case report: Adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome.

Authors:  Michael Herman Chui; Michael Herman Chui; Nese Colak Ozbey; Shereen Ezzat; Yersu Kapran; Yesim Erbil; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.